Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

GSK's TNF-R1-targeting antibody attenuates pulmonary inflammation

May 19, 2014

ZN-6168 demonstrates excellent safety and pharmacokinetic profile in animal studies

May 19, 2014

New periostin-targeting therapy for the treatment of choroidal FVM

May 19, 2014

MedImmune provides phase I results for anti-alpha toxin MAb

May 19, 2014

Novel claudin-targeting antibodies show potential antitumor and antiviral activity

May 19, 2014

ZN-2007 as a novel HCV NS3 inhibitor with excellent in vivo activity and safety

May 16, 2014

TNF-alpha in saliva tested as a potential biomarker for carotid atherosclerosis

May 16, 2014

LassBio-1386 investigated for the treatment of PAH in a rat model

May 16, 2014

Clinical trial tests the efficacy, safety and tolerability of selisistat

May 16, 2014

Results of a first-in-human phase I/II study with SA4Ag vaccine

May 16, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...